Preview

Вестник трансплантологии и искусственных органов

Расширенный поиск

Рак легкого у реципиентов солидных органов

https://doi.org/10.15825/25/1995-1191-2021-4-19-25

Полный текст:

Аннотация

Рак легкого остается ведущей причиной смерти в популяции среди всех злокачественных новообразований. Реципиенты солидных органов находятся в группе риска развития злокачественных новообразований, включая рак легкого, за счет длительного приема иммуносупрессивных препаратов. Развитие онкологических заболеваний, включая рак легкого, у этой категории больных отличается рядом особенностей. Кроме того, злокачественные новообразования у реципиентов солидных органов трудно поддаются лечению и имеют худший прогноз. Изучению вопросов, касающихся механизмов развития, методов скрининга и лечения рака легкого у реципиентов солидных органов, посвящен данный обзор.

Об авторах

А. В. Никулин
ФГБУ «Национальный медицинский исследовательский центр трансплантологии и искусственных органов имени академика В.И. Шумакова» Минздрава России
Россия

Никулин Андрей Владимирович

123182, Москва, ул. Щукинская, д. 1

Тел. (495) 190-35-62

 



И. В. Пашков
ФГБУ «Национальный медицинский исследовательский центр трансплантологии и искусственных органов имени академика В.И. Шумакова» Минздрава России
Россия

Москва



Я. С. Якунин
ФГБУ «Национальный медицинский исследовательский центр трансплантологии и искусственных органов имени академика В.И. Шумакова» Минздрава России
Россия

Москва



Список литературы

1. Bade BC, Dela Cruz CS. Lung Cancer 2020: Epidemiology, Etiology and Prevention. Clin Chest Med Elsevier Inc. 2020; 41 (1): 1–24. doi: 10.1016/j.ccm.2019.10.001.

2. Wareham NE et al. Risk of de novo or secondary cancer after solid organ or allogeneic haematopoietic stem cell transplantation. J Cancer Res Clin Oncol Springer Berlin Heidelberg. 2019; 145 (12): 3125–3135. doi: 10.1007/s00432-019-03039-2.

3. Shtraichman O, Ahya VN. Malignancy after lung transplantation. Ann Transl Med. 2020; 8 (6): 416–416. doi: 10.21037/atm.2020.02.126.

4. Rousseau-Gazaniol C et al. Lung cancer in renal transplant recipients: A case-control study. Lung Cancer Elsevier Ireland Ltd. 2017; 111: 96–100. doi: 10.1016/j.lungcan.2017.07.011.

5. Acuna SA. Etiology of increased cancer incidence after solid organ transplantation. Transplant Rev Elsevier Inc. 2018; 32 (4): 218–224. doi: 10.1016/j.trre.2018.07.001.

6. Katabathina VS et al. Malignancy after solid organ transplantation: Comprehensive imaging review. Radiographics. 2016; 36 (5): 1390–1407. doi: 10.1148/rg.2016150175.

7. Yanik EL et al. Cancer risk after pediatric solid organ transplantation. Pediatrics. 2017; 139 (5). doi: 10.1542/peds.2016-3893.

8. Potaris K et al. Lung cancer after heart transplantation: A 17-year experience. Ann Thorac Surg. 2005; 79 (3):980–983. doi: 10.1016/j.athoracsur.2004.05.021.

9. Drevet G et al. Lung cancer surgical treatment after solid organ transplantation: A single center 30-year experience. Lung Cancer Elsevier. 2020; 139: 55–59. doi: 10.1016/j.lungcan.2019.10.023.

10. Robbins HY, Arcasoy SM. Malignancies Following Lung Transplantation. Clin Chest Med. 2011; 32 (2): 343–355. doi: 10.1016/j.ccm.2011.02.011.

11. Olland ABM et al. Primary lung cancer in lung transplant recipients. Ann Thorac Surg Elsevier Inc. 2014; 98 (1):362–371. doi: 10.1016/j.athoracsur.2014.04.014.

12. Noone AM et al. Cancer-attributable mortality among solid organ transplant recipients in the United States: 1987 through 2014. Cancer. 2019; 125 (15): 2647–2655. doi: 10.1002/cncr.32136.

13. Yanik EL et al. Comparison of cancer diagnoses between the US solid organ transplant registry and linked central cancer registries. Am J Transplant. 2016; 16 (10):2986–2993. doi: 10.1111/ajt.13818.

14. Pérez-Callejo D et al. Lung cancer in lung transplantation: Incidence and outcome. Postgrad Med J. 2018; 94 (1107): 15–19. doi: 10.1136/postgradmedj-2017-134868.

15. Choi YJ et al. Incidental lung cancer of explanted lungs from lung transplant recipients: Incidence, characteristics, and 5-year survival. Yonsei Med J. 2020; 61 (11):958–964. doi: 10.3349/ymj.2020.61.11.958.

16. Sonbol MB et al. A Case of Donor-Transmitted Non- Small Cell Lung Cancer After Liver Transplantation: An Unwelcome Guest. Oncologist. 2019; 24 (6): 2018–2020. doi: 10.1634/theoncologist.2018-0517.

17. Chatron E et al. Lung cancer after lung transplantation: An analysis of 25 years of experience in a single institution. Clin Transplant. 2019; 33 (1): 0–2. doi: 10.1111/ctr.13446.

18. Ekström M, Riise GC, Tanash HA. Risk of cancer after lung transplantation for COPD. Int J COPD. 2017; 12:2841–2847. doi: 10.2147/COPD.S147065.

19. Verleden GM, Fisher AJ. Lung transplantation and lung cancer: Is there a link? Respiration. 2011; 81 (6): 441–445. doi: 10.1159/000326934.

20. Triplette M et al. HHS Public Access. 2020; 19 (5):1478–1490. doi: 10.1111/ajt.15181.

21. Gershman E et al. Characteristics of lung cancer in idiopathic pulmonary fibrosis with single lung transplant versus non-transplanted patients: A retrospective observational study. BMJ Open Respir Res. 2020; 7 (1): 1–6. doi: 10.1136/bmjresp-2020-000566.

22. Vajdic CM, Van Leeuwen MT. Cancer incidence and risk factors after solid organ transplantation. Int J Cancer. 2009; 125 (8): 1747–1754. doi: 10.1002/ijc.24439.

23. Asch WS, Perazella MA. Cancer and Mortality in Solid- Organ Transplantation: Preventable or Inevitable? Am J Kidney Dis. 2016; 68 (6): 839–842. doi: 10.1053/j.ajkd.2016.06.009.

24. Huo Z et al. Cancer Risks in Solid Organ Transplant Recipients: Results from a Comprehensive Analysis of 72 Cohort Studies. Oncoimmunology. Taylor & Francis. 2020; 9 (1). doi: 10.1080/2162402X.2020.1848068.

25. Brennan DC et al. Development of malignancy following solid organ transplantation. UpToDate. 2016; 10:1–20.

26. Endén K et al. Cancer morbidity and mortality after pediatric solid organ transplantation – a nationwide register study. Pediatric Nephrology. 2020; 35 (9): 1719–1728. doi: 10.1007/s00467-020-04546-y.

27. Fogel AL, Miyar M, Teng JMC. Cutaneous Malignancies in Pediatric Solid Organ Transplant Recipients. Pediatr Dermatol. 2016; 33 (6): 585–593. doi: 10.1111/pde.12941.

28. Belli EV et al. Lung cancer following lung transplant: Single institution 10 year experience. Lung Cancer. Elsevier Ireland Ltd. 2013; 81 (3): 451–454. doi: 10.1016/j.lungcan.2013.05.018.

29. Acuna SA et al. Cancer Screening Recommendations for Solid Organ Transplant Recipients: A Systematic Review of Clinical Practice Guidelines. Am J Transplant. 2017; 17 (1): 103–114. doi: 10.1111/ajt.13978.

30. Godoy MCB et al. Understanding Lung-RADS 1.0: A Case-Based Review. Semin Ultrasound, CT MRI Elsevier. 2018; 39 (3): 260–272. doi: 10.1053/j.sult.2018.03.001.

31. American College of Radiology. Lung-RADS® Version 1.1 Assessment Categories. 2019; 3.

32. Robinson C, Chanchlani R, Kitchlu A. Malignancies after pediatric solid organ transplantation. Pediatric Nephrology. 2020. doi: 10.1007/s00467-020-04790-2.

33. Wang X, Dong M. Malignancy After Lung Transplantation: How to Manage Immunosuppression? Transplant Proc Elsevier Inc. 2020; 52 (1): 315–320. doi: 10.1016/j.transproceed.2019.09.012.

34. Engels EA. Cancer in Solid Organ Transplant Recipients: There Is Still Much to Learn and Do. Am J Transplant. 2017; 17 (8): 1967–1969. doi: 10.1111/ajt.14140.

35. Wong K et al. Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Metastatic Cancer Post Solid Organ Transplantation: A Case Report and Review of the Literature. Transplant Proc Elsevier Inc. 2019; 51 (9):3053–3058. doi: 10.1016/j.transproceed.2019.08.002.

36. Acuna SA et al. Cancer recurrence after solid organ transplantation: A systematic review and meta-analysis. Transplant Rev Elsevier Inc. 2017; 31 (4): 240–248. doi: 10.1016/j.trre.2017.08.

37. Buxeda A et al. Gender differences in cancer risk after kidney transplantation. Oncotarget. 2019; 10 (33):3114–3128. doi: 10.18632/oncotarget.26859.

38. Chen H et al. Stereotactic ablative radiotherapy for earlystage lung cancer following double lung transplantation. Radiat Oncol Radiation Oncology. 2018; 13 (1): 10–14. doi: 10.1186/s13014-018-1089-8.

39. Drevet G et al. Lung cancer surgical treatment after solid organ transplantation: a single center 30-year experience. Lung Cancer. 2020; 145: 222–224. doi: 10.1016/j.lungcan.2019.10.023.

40. Falcoz PE et al. Video-assisted thoracoscopic surgery versus open lobectomy for primary non-small-cell lung cancer: A propensity-matched analysis of outcome from the European Society of Thoracic Surgeon database. Eur J Cardio-thoracic Surg. 2016; 49 (2): 602–609. doi: 10.1093/ejcts/ezv154.

41. Demmy T, Dexter E. Overview of minimally invasive thoracic surgery. UpToDate. 2019; 1–84.

42. Cheng X et al. Minimally Invasive Thoracic Surgery 3.0. Ann Surg. 2018; 267 (1): 37–38. doi: 10.1097/SLA.0000000000002.

43. Xia ZN et al. Laparoscopic-Assisted Resection for Advanced Colorectal Cancer in Solid Organ Transplant Recipients. J Investig Surg. Taylor & Francis. 2018; 31 (6):483–490. doi: 10.1080/08941939.2017.1359707.

44. Al-Ameri M et al. Uniportal versus multiportal videoassisted thoracic surgery for lung cancer. J Thorac Dis. 2019; 11 (12): 5152–5161. doi: 10.21037/jtd.2019.12.01.

45. Cao C et al. European questionnaire on the clinical use of video-assisted thoracoscopic surgery. Interact Cardiovasc Thorac Surg. 2018; 27 (3): 379–383. doi: 10.1093/icvts/ivy062.

46. Seitlinger J et al. Conversion from video-assisted thoracic surgery (VATS) to thoracotomy during major lung resection: how does it affect perioperative outcomes? Interact Cardiovasc Thorac Surg. 2021; 32 (1): 55–63. doi: 10.1093/icvts/ivaa220.

47. Maeda H et al. Video-assisted thoracoscopic surgery after renal transplantation: A single-institution experience. Asian J Endosc Surg. 2016; 9 (1): 37–43. doi: 10.1111/ases.12248.

48. Chen LN et al. Characteristics and outcomes of lung cancer in solid organ transplant recipients. Lung Cancer Elsevier. 2020; 146: 297–302. doi: 10.1016/j.lungcan.2020.06.018.

49. Zhang SX, Liu Y. Primary lung cancer in Chinese renal transplant recipients: a single-center analysis. Nan Fang Yi Ke Da Xue Xue Bao. 2017; 37 (6): 715–720. doi: 10.3969/j.issn.1673-4254.2017.06.01.

50. Sigel K et al. Lung cancer prognosis in elderly solid organ transplant recipients. Transplantation. 2015; 99 (10): 2181–2189. doi: 10.1097/TP.0000000000000715.

51. https://gco.iarc.fr [Internet]. International Agency for Research on Cancer. Available from: https://gco.iarc.fr.

52. http://www.transplant-observatory.org [Internet]. Global Observatory on Donation and Transplantation. Available from: http://www.transplant-observatory.org.


Рецензия

Для цитирования:


Никулин А.В., Пашков И.В., Якунин Я.С. Рак легкого у реципиентов солидных органов. Вестник трансплантологии и искусственных органов. 2021;23(4):19-25. https://doi.org/10.15825/25/1995-1191-2021-4-19-25

For citation:


Nikulin A.V., Pashkov I.V., Yakunin Y.S. Lung cancer in solid organ transplant recipients. Russian Journal of Transplantology and Artificial Organs. 2021;23(4):19-25. https://doi.org/10.15825/25/1995-1191-2021-4-19-25

Просмотров: 190


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1995-1191 (Print)
ISSN 2412-6160 (Online)